Recent advances in and therapeutic potential of muscle-derived stem cells

Journal of Cellular Biochemistry

Volumn 85, Issue SUPPL. 38, 2002, Pages 80-87

  O'Brien, Kristine ^a   Muskiewicz, Kristina ^a   Gussoni, Emanuela ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Mesenchyme; Muscle stem cell; Myoblast transfer; Satellite cell

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; GENE TARGETING; MITOSIS; MONONUCLEAR CELL; PLASTICITY; PRIORITY JOURNAL; STEM CELL; TISSUE INJURY; ANIMAL; BIOLOGICAL THERAPY; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; HUMAN; MULTIPOTENT STEM CELL; REGENERATION; REVIEW; SKELETAL MUSCLE; TRANSPLANTATION;

BIOLOGICAL MARKER;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; MULTIPOTENT STEM CELLS; MUSCLE, SKELETAL; REGENERATION; TISSUE THERAPY;

EID: 0036244302     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10051     Document Type: Article

References (40)

1. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source
2. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells
3. The satellite cell and muscle regeneration
4. Skeletal muscle formation in vertebrates
5. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells
6. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration
7. Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells
8. Muscle regeneration by bone marrow-derived myogenic progenitors
9. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
10. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation
11. The fate of individual myoblasts after transplantation into muscles of DMD patients
12. Dystrophin expression in the mdx mouse restored by stem cell transplantation
13. The embryonic origin of muscle
14. Human myoblast transplantation: Preliminary results of 4 cases
15. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions
16. Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles
17. Hematopoietic potential of stem cells isolated from murine skeletal muscle
18. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: Potential for rapid isolation of muscle-derived stem cells
19. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation
20. Myoblast transfer in Duchenne muscular dystrophy
21. Myoblast transfer therapy for Duchenne muscular dystrophy
22. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
23. Effect of bone morphogenetic protein-2 -expressing musclederived cells on healing of critical-sized bone defects in mice
24. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin
25. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle
26. Satellite cells of skeletal muscle
27. Myoblast transfer in the treatment of Duchenne's muscular dystrophy
28. Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer
29. Arterial delivery of myoblasts to skeletal muscle
30. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy
31. Dedifferentiation of mammalian myotubes induced by msx1
32. Evidence of fusion between host and donor myoblasts in muscle grafts
33. Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts
34. Development of approaches to improve cell survival in myoblast transfer therapy
35. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy
36. A new look at the origin, function, and "stem-cell" status of muscle satellite cells
37. Pax7 is required for the specification of myogenic satellite cells
38. Intraarterial injection of muscle-derived CD34(+)Sca-l(+) stem cells restores dystrophin in mdx mice
39. Muscle-derived cell transplantation and differentiation into lower urinary tract smooth muscle
40. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype